iSpecimen Inc (ISPC)
4.56
-0.37
(-7.51%)
USD |
NASDAQ |
Nov 05, 16:00
4.56
0.00 (0.00%)
After-Hours: 16:00
iSpecimen Profit Margin (Quarterly): -73.65% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -73.65% |
| March 31, 2024 | -126.7% |
| December 31, 2023 | -119.3% |
| September 30, 2023 | -76.00% |
| June 30, 2023 | -214.4% |
| March 31, 2023 | -82.43% |
| December 31, 2022 | -72.92% |
| September 30, 2022 | -119.8% |
| June 30, 2022 | -111.5% |
| March 31, 2022 | -94.64% |
| Date | Value |
|---|---|
| December 31, 2021 | -80.44% |
| September 30, 2021 | -57.13% |
| June 30, 2021 | -48.04% |
| March 31, 2021 | -133.7% |
| December 31, 2020 | -58.64% |
| September 30, 2020 | -55.40% |
| June 30, 2020 | -11.57% |
| March 31, 2020 | -95.70% |
| December 31, 2019 | -104.5% |
| September 30, 2019 | -304.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-214.4%
Minimum
Jun 2023
-11.57%
Maximum
Jun 2020
-91.40%
Average
-82.43%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| RadNet Inc | -0.65% |
| 23andMe Holding Co | -171.7% |
| Delcath Systems Inc | -176.9% |
| CytoSorbents Corp | -46.86% |
| Progyny Inc | 5.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -101.8% |
| Return on Assets | -68.79% |
| Return on Invested Capital | -101.8% |
| Gross Profit Margin (Quarterly) | 50.26% |
| Operating Margin (Quarterly) | -76.18% |
| Return on Net Operating Assets | -104.4% |